Saizen 60UI is a pharmaceutical product that contains the active ingredient somatropin, which is a synthetic form of human growth hormone (HGH). It is available in the form of a lyophilized powder that is reconstituted with a specific diluent before administration.
Saizen 60UI is primarily used for the treatment of growth hormone deficiency (GHD) in children and adults. Growth hormone deficiency is a medical condition where the body does not produce enough growth hormone, leading to impaired growth and development. Saizen helps to supplement the deficient growth hormone levels and stimulate growth in individuals with GHD.
Saizen 60UI is typically administered through subcutaneous (under the skin) injections. The exact dosage and treatment duration are determined by a healthcare professional based on the individual’s specific needs and medical condition.